Ventus Therapeutics U.S., Inc.
Pharmaceutical company · Waltham, Massachusetts, United States
Ventus Therapeutics U.S., Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $70 million sold in a notice filed in 2022.
Ventus Therapeutics U.S. at a glance
What does Ventus Therapeutics U.S. do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $70 million sold (2022).
Frequently asked questions about Ventus Therapeutics U.S.
Where is Ventus Therapeutics U.S. headquartered?
Ventus Therapeutics U.S., Inc. is headquartered in Waltham, Massachusetts, United States.
What does Ventus Therapeutics U.S. do?
Ventus Therapeutics U.S., Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Ventus Therapeutics U.S. founded?
The earliest incorporation on record for Ventus Therapeutics U.S., Inc. is in 2019, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences